Clinical Decision Support System Offered by
VisualDx to Health Care Professionals for 90 Days at No
Cost
Henry Schein Medical, the U.S. medical business of Henry Schein,
Inc., announced today the availability of VisualDx to assist health
care professionals seeing patients virtually or in person amid the
novel COVID-19 outbreak. The web-based, clinical decision support
system is designed to enhance diagnostic accuracy, aid therapeutic
decisions, and improve patient care, all critically important for
clinicians on the front lines of medicine.
VisualDx, which can be accessed from a computer desktop, tablet
or mobile application, helps health care professionals navigate
diagnostic challenges by using the software to enhance clinical
decision-making. With VisualDx, a clinician can build a custom
differential diagnosis; search by disease for quick therapy and
treatment options; review and compare a curated medical image
library; understand medication reactions; and share patient
handouts via email.
“As health care professionals treat and diagnose patients amid
the COVID-19 outbreak, it is an opportune time to leverage VisualDx
to provide solutions health care providers can rely on to deliver
fast, high-quality health care and offer accurate diagnosis and
treatment,” said Michael Casamassa, Vice President of Solutions,
Henry Schein Medical. “VisualDx will help providers who are still
seeing patients in their physical setting, as well as those using
our telemedicine solution, Medpod®, to help augment their thinking
when treating and diagnosing patients.”
Available as one of Henry Schein Medical’s SolutionHub™ clinical
support solutions, VisualDx can support common and complex
diagnostic cases including rashes, variant presentations of
symptoms, and emerging infectious diseases. The software is
relevant for a range of health care specialties, including: Family
Medicine, Internal Medicine, Urgent Care, Infectious Disease,
Dermatology, Emergency Medicine, Pediatrics, Risk Management, and
Medical Education.
“We are proud to team up with Henry Schein, a fellow New York
company, to provide our health care workers with the tools needed
to ‘raise the line’ via virtual care and decision support
solutions,” said Art Papier, MD, CEO of VisualDx. “We applaud all
clinicians, both on the frontline of the COVID-19 pandemic and
those handling the rest of medicine. We believe our decision
support software provides clinicians with the aid needed to handle
important diagnoses and gives worried patients peace of mind as
well.”
In order to participate in VisualDx’s 90 day offer, health care
professionals have to activate their account with VisualDx by May
31 to receive VisualDx for up to 90 days, at no cost, with no
credit card required. To sign up for this VisualDx offer, visit
www.visualdx.com/raisetheline. To learn more about Henry Schein
Medical’s SolutionsHub, visit
https://www.henryscheinsolutionshub.com/.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for
health care professionals powered by a network of people and
technology. With more than 19,000 Team Schein Members worldwide,
the Company's network of trusted advisors provides more than 1
million customers globally with more than 300 valued solutions that
improve operational success and clinical outcomes. Our Business,
Clinical, Technology, and Supply Chain solutions help office-based
dental and medical practitioners work more efficiently so they can
provide quality care more effectively. These solutions also
support dental laboratories, government and institutional
healthcare clinics, as well as other alternate care sites. Henry
Schein operates through a centralized and automated distribution
network, with a selection of more than 120,000 branded products and
Henry Schein private-brand products in stock, as well as more than
180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index,
Henry Schein is headquartered in Melville, N.Y., and has operations
or affiliates in 31 countries. The Company's sales from continuing
operations reached $10.0 billion in 2019, and have grown at a
compound annual rate of approximately 13 percent since Henry Schein
became a public company in 1995.
For more information, visit Henry Schein
at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein
on Twitter.
About VisualDx:
VisualDx is a Rochester, NY-based company dedicated to improving
healthcare decision making and reducing diagnostic errors. Its
professional product, VisualDx, is the award-winning diagnostic
clinical decision support system that has become the standard
professional resource at more than 2,300 hospitals worldwide and
over half the U.S. medical schools.
VisualDx is also dedicated to empowering patients and consumers
and is the maker of Aysa, a consumer A.I. enabled dermatology app
available for iOS and Android and skinsight.com. Aysa enables
consumers to take a picture of a rash or skin issue and get
guidance on next steps.
VisualDx, along with its consumer tool Aysa, combines problem
oriented clinical search with the world's best curated medical
image library, plus medical knowledge from experts and
sophisticated machine learning algorithms to help with differential
diagnosis, variation, treatment, and patient communication.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200413005178/en/
Ann Marie Gothard Vice President, Corporate Media Relations
annmarie.gothard@henryschein.com (631) 390-8169
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From Apr 2024 to May 2024
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From May 2023 to May 2024